PDI - Resultado de Búsqueda

Marcelo Adan Garrido Salvo

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Gastric cancer treatments, tumor heterogeneity and targeted therapies, precision oncology

Medico cirujano, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1997
Internal Medicine, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2001
Sub-Specialization in Oncology and Hematology, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2007
Medicine, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1995
Training in gastrointestinal Oncology and Neuroendocrine Tumors, Hospital Universitario Central de Asturias. España, 2013

Instructor Full Time

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Medicina

Santiago, Chile

2003 - 2007
Profesor Asistente Full Time

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Medicina

Santiago, Chile

2007 - 2018
Full professor of Dirección Innovación y Transferencia Tecnológica Full Time

UNIVERSIDAD MAYOR

Santiago, Chile

2021 - A la fecha
Associated Professor Full Time

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Medicina

Santiago, Chile

2019 - 2021

Medico intensivista Full Time

HOSPITAL DE LOS ANDES

Los Andes, Chile

2002 - 2003
Medical director Part Time

Centro de Oncología de Precisión, Universidad Mayor

Santiago, Chile

2021 - A la fecha
Chief of Onco-Hematology, Medical Oncology and Gastrointestinal Oncology Part Time

Clínica Indisa

Santiago, Chile

2021 - A la fecha
Principal Investigator Part Time

Centro de Estudios Clínicos SAGA

Santiago, Chile

2021 - A la fecha
Gastrointestinal Oncology and Oncology Clinical Trials Part Time

Red de Salud UC Christus (Clinica San Carlos de Apoquindo)

Santiago, Chile

2014 - 2021

Beca Presidente de la Republica

Gobierno de Chile

Chile, 1992

Beca de estudios entregada por S.E. Presidente Patricio Aylwin Azocar
Premio al mejor graduado

UNIVERSIDAD AUSTRAL DE CHILE

Chile, 1995

Premio al mejor graduado de Medicina
Beca Medicina Interna

MINISTERIO DE SALUD

Chile, 1998

Beca de Medicina interna UC
Beca de Oncologia

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Chile, 2004

Beca del Departamento de Hematologia y Oncologia PUC
Prominent Oncologist Prize

Sociedad Latinoamericana de Oncología Gastroenterológica

Chile, 2019

Prominent Oncologist Prize given by the Sociedad Latinoamericana de Oncología Gastroenterológica for his contribution to the field


Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population Garrido, Marcelo; Miquel, Juan Francisco Article ISI PHARMACEUTICS (2024)
Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer Goralsky, Lauren; Garrido, Marcelo Article ISI FRONTIERS IN ONCOLOGY (2024)
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries Medel-Jara, Patricio; Reyes Placencia, Diego; Anton, Rosario; Jimenez, Elena; Miralles-Marco, Ana; Caballero, Carmelo; Boggino, Hugo; Barros, Rita; Santos-Antunes, Joao; Diez, Marc; et al. Article ISI UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2024)
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus Garrido, Marcelo Article ISI FUTURE ONCOLOGY (2023)
Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients Bravo, MariaLoreto; Fernandez, M. Fernanda; Garrido, Marcelo Article ISI INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649 Cella, David; Garrido, Marcelo; Montesarchio, Vincenzo; Hunter, Shannon; Davenport, Eric; Wang, Jinyi Article ISI JOURNAL OF CLINICAL ONCOLOGY (2023)
Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study Briones, Juan; Koch, Erica; Pizarro, Gonzalo; Acevedo, Francisco; Norero, Enrique; Garrido, Marcelo Article ISI VALUE IN HEALTH REGIONAL ISSUES (2023)
Local advances and challenges in the molecular diagnosis of solid tumors: a health perspective towards precision oncology in Chile Selman-Bravo, Carolina; Moyano, Leonor; Bustos, Juan Carlos; Plaza-Parroquia, Francisca; Garrido, Marcelo Article ISI SCIELO REVISTA MEDICA DE CHILE (2023)
Nivolumab plus ipilimumab vs chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma: CheckMate 649 biomarker analyses Ajani, Jaffer; Yao, Jin; Garrido, Marcelo; Gallardo, Carlos; Bragagnoli, Arinilda; Karamouzis, Michalis; Nathani, Raheel; Novosiadly, Ruslan Article ISI CANCER RESEARCH (2023)
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study Wainberg, Z. A.; Molena, D.; Hyung, W. J.; Omori, T.; Cunha Sousa Oliveira, S.; Liberman, M.; Castro Oliden, V.; Bilici, M.; Kurland, J.; Xynos, I.; et al. Article ISI ANNALS OF ONCOLOGY (2023)
Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study Rha, S. Y.; Wyrwicz, L. S.; Weber, P. E. Y.; Ryu, M. H.; Alves, G. V.; Shiu, K. -k.; Fernandez, M. Gonzalez; Lowery, M.; Cil, T.; Cruz, F. J. S. M.; et al. Article ISI ANNALS OF ONCOLOGY (2023)
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 Trial Chan, Stephen Lam; Garrido, Marcelo; Knox, Jennifer; Cattan, Stephane; Martinez-Forero, Ivan; Wei, Ziwen; Liu, Chih-Chin Article ISI LIVER CANCER (2023)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Rha, Sun Young; Oh, Do-Youn; Ryu, Min-Hee; Lee, Jeeyun; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernandez, Manuel Gonzalez; Lowery, Maeve A.; Cil, Timucin; et al. Article ISI LANCET ONCOLOGY (2023)
Real-world gastric cancer (GC) in Latin America (LATAM) and Europe (EU) Freile, B.; Derks, S.; van Schooten, T.; Colas, C. V. Gauna; Fernandez-Figueroa, E.; Takahashi, A. M. Leon; Luca, M. R.; O'Connor, J. M. R.; Esteso, F.; Fleitas, T. C. Article ISI ANNALS OF ONCOLOGY (2023)
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab plus Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study Garrido, Marcelo; Castro, Hugo R.; Cao, Z. Alexander; Aurora-Garg, Deepti; Kobie, Julie; Cristescu, Razvan Article ISI CLINICAL CANCER RESEARCH (2022)
First-line treatment with immune checkpoint inhibitors (ICI) for metastatic gastric and esophagogastric junction (EGJ) adenocarcinoma in Latin America: Sociedad Latinoamericana de Gastroenterologia Oncologica (SLAGO) evidence-based recommendations Diaz, Maria Celeste; Diaz, Consuelo; O'Connor, Juan Manuel; Garrido, Marcelo; Montenegro, Paola Catherine; Peixoto, Renata D'Alpino Article ISI JOURNAL OF CLINICAL ONCOLOGY (2022)
Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience Regonesi, Carlos; Cereceda, Luis; Majlis, Alejandro; Fassler, Andre; León, María Elisa; Rodriguez, Maria Paz Z.; Berkovits, Alejandro; Garrido, Marcelo Article ISI JOURNAL OF PERSONALIZED MEDICINE (2022)
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma Doki, Y.; Motoyama, S.; Ogata, T.; Hsu, C. -H.; Adenis, A.; El Hajbi, F.; Braghiroli, M. I.; Holtved, E.; Ostoich, S. A.; Kim, H. R.; et al. Article ISI NEW ENGLAND JOURNAL OF MEDICINE (2022)
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer Shitara, Kohei; Ajani, Jaffer A.; Moehler, Markus; Garrido, Marcelo; Gallardo, Carlos; Shen, Lin; Yamaguchi, Kensei; Wyrwicz, Lucjan; Skoczylas, Tomasz; Bragagnoli, Arinilda Campos; et al. Article ISI NATURE (2022)
Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial Lee, Keun Wook; Garrido, Marcelo; Chung, Hyun Cheol Cheol; Castro-Salguero, Hugo Raul Article ISI JOURNAL OF CLINICAL ONCOLOGY (2022)
Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: a case report Pizarro, Gonzalo; Koch, Elard; Hernandez, Mauricio; Paz Rodriguez, Maria Z.; Berkovits, Alejandro; Garrido, Marcelo Article ISI JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally van Schooten, Tessa Suzanne; Derks, Sarah; Jimenez-Marti, Elena; Carneiro, Fatima; Figueiredo, Ceu; Ruiz, Erika; Molero, Cristina; Garrido, Marcelo; Manuel O'Connor, Juan; Esteso, Federico; et al. Article ISI BMC CANCER (2022)
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer Hill, Charlotte N.; Garrido, Marcelo Article ISI BMC CANCER (2021)
Case Report: Molecular Features and Treatment Options for Small Bowel Adenocarcinoma Pizarro, Gonzalo; Garrido, Marcelo Article ISI FRONTIERS IN ONCOLOGY (2021)
CheckMate 8KX: Phase 1/2 multitumor preliminary analyses of a subcutaneous formulation of nivolumab (± rHuPH20). Jackson, Christopher G. C. A.; O'Donnell, Anne; Bahleda, Rastilav; Garrido, Marcelo; Latten-Jansen, Loes; Yimer, Habte Aragaw; Camacho, Trixia; Konduri, Srivani; Aras, Urvi; Sanghavi, Kinjal; et al. Article ISI JOURNAL OF CLINICAL ONCOLOGY (2021)
Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A 4-Decade Experience San Francisco, Ignacio F.; Macchiavelo, Stefano; Zuniga, Alvaro; Garrido, Marcelo; Huete, Alvaro; Cortínez, Ignacio; Zemelman, Jose Tomas; Cifuentes, Joaquin; Castro, Fernando; Olivari, Daniela; et al. Article ISI JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥ 10 Fuchs, Charles S.; Muro, Kei; Varga, Eniko; Chen, Jen-Shi; Hochhauser, Daniel; Thuss-Patience, Peter; Al-Batran, Salah-Eddin; Garrido, Marcelo; Shih, Chie-Schin Article ISI CLINICAL CANCER RESEARCH (2021)
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Martinez de Castro, Eva; Pericay Pijaume, Carles; Castro Unanua, Natalia; Cano, Juana Maria; Garrido, Marcelo; Sanchez Canovas, Manuel; Limon, Maria Luisa; Longo, Federico; Arias-Martinez, Aranzazu; Sauri, Tamara; et al. Article ISI GASTRIC CANCER (2021)
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649. Moehler, Markus H.; Garrido, Marcelo; Bragagnoli, Arinilda Silva Campos; Yanez, Patricio Eduardo; Memaj, Arteid Article ISI JOURNAL OF CLINICAL ONCOLOGY (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial Garrido, Marcelo; Cullen, Dana Article ISI LANCET (2021)
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240 Ryoo, Baek-Yeol; Merle, Philippe; Kulkarni, Amit S.; Cheng, Ann-Lii; Lim, Ho Yeong; Breder, Valeriy; Chao, Yee; Ogasawara, Sadahisa; Garrido, Marcelo; Daniele, Bruno; et al. Article ISI CANCER (2021)
Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the randomized, phase 3 KEYNOTE-240 study. Garrido, Marcelo Article ISI JOURNAL OF CLINICAL ONCOLOGY (2021)
Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of the randomized, phase III KEYNOTE-240 study. Garrido, Marcelo; Siegelb, Abby B. Article ISI JOURNAL OF CLINICAL ONCOLOGY (2021)
Oncological resection, myasthenia gravis and staging as prognostic factors in thymic tumours: a Chilean case series Eliana Solovera, Maria; Bannura, Felipe; Garrido, Marcelo; Koch, Erica; Acevedo, Francisco; Madrid, Jorge; Valbuena, Jose Article ISI ECANCERMEDICALSCIENCE (2021)
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data Acevedo, Francisco; Medina, Lidia; Camus, Mauricio; Madrid, Jorge; Koch, Erica; Garrido, Marcelo Article ISI ECANCERMEDICALSCIENCE (2021)
Pembrolizumab (pembro) versus placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase 3 KEYNOTE-240 study. Garrido, Marcelo Article ISI JOURNAL OF CLINICAL ONCOLOGY (2021)
Pembrolizumab (pembro) vs placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase III KEYNOTE-240 study. Garrido, Marcelo; Breder, Valeriy Vladimirovich; Rahman, Ahmadur Article ISI JOURNAL OF CLINICAL ONCOLOGY (2021)
Update on neuroendocrine tumors Carrillo, Diego; Pinto, Mauricio; Bravo, Maria L.; Valenzuela, Yasna; Nilo, Flavia; Bello, Fernando; Orellana, Pilar; Carlos Quintana, Juan; Torres, Paula J.; Luis Leal, Jose; et al. Article ISI REVISTA MEDICA DE CHILE (2021)
A molecular classification of gastric cancer in Chilean patients Garrido, Marcelo Article ISI CANCER RESEARCH (2020)
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability Loreto Bravo, M.; Acevedo, Francisco; Koch, Erica; Madrid, Jorge; Torres, Javiera; Garrido, Marcelo Article ISI CANCERS (2020)
Clinical, biological and translational significance in gastric cancer of <i>reprimo</i>-<i>like</i> gene, an uncharacterized member of the <i>reprimo</i> gene family Rodriguez, Andres; Garrido, Marcelo; Amigo, Julio; Gonzalez, Robinson; Aravena, Edmundo Article ISI CANCER RESEARCH (2020)
Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer Pinto, M. P.; Bravo, M. L.; Koch E.; Vines E. Article ISI SCOPUS CLINICAL LUNG CANCER (2020)
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial Fuchs, Charles; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Villanueva, Luis; Goekkurt, Eray; et al. Article ISI JAMA ONCOLOGY (2020)
First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution Acevedo, Francisco; Medina, Lidia; Camus, Mauricio; Madrid, Jorge; Koch, Erica; Garrido, Marcelo Article ISI CURRENT MEDICAL RESEARCH AND OPINION (2020)
Living Donor Liver Transplantation for Imatinib-Resistant Gastrointestinal Stromal Tumor Liver Metastases: A New Therapeutic Option in Transplant Oncology Garrido, Marcelo; Dib, Martin; Torres, Javiera; Guerra, Juan F.; Fernandes, Eduardo; Martinez, Jorge A. Article ISI LIVER TRANSPLANTATION (2020)
Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover Alexander, Katie L.; Serrano, Carolina A.; Chakraborty, Asmi; Nearing, Marie; Council, Leona N.; Riquelme, Arnoldo; Garrido, Marcelo; Bellis, Susan L.; Smythies, Lesley E.; Smith, Phillip D. Article ISI JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study Moehler, M.; Yamaguchi, K.; Skoczylas, T.; Campos Bragagnoli, A.; Yanez, P.; Tehfe, M.; Poulart, V.; Ajani, J. A.; Janjigian, Y. Y. Article ISI ANNALS OF ONCOLOGY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial Article ISI SCOPUS JOURNAL OF CLINICAL ONCOLOGY (2020)
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities Madrid, Jorge; Acevedo, Francisco; Koch, Erica; Garrido, Marcelo Article ISI JCO GLOBAL ONCOLOGY (2020)
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry Cotes Sanchis, Almudena; Gallego, Javier; Arrazubi, Virginia; Custodio, Ana; Maria Cano, Juana; Aguado, Gema; Macias, Ismael; Lopez, Carlos; Lopez, Flora; Visa, Laura; et al. Article ISI PLOS ONE (2020)
The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer Alejandra Alarcon, Maria; Amigo, Julio; Norero, Enrique; Garrido, Marcelo Article ISI INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective Pinto, MP; Medel, MM; Retamal, IN; Bravo, ML; Valenzuela, Y; Galindo, H; Pena J.; Madrid J.; Nilo, F.; Guarda, FJ; et al. Article ISI SCOPUS HORMONES & CANCER (2019)
High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study Munoz-Medel, Matias; Fernandez, Maria F.; Acevedo, Francisco; Madrid, Jorge; Koch, Erica; Jose Maturana, Maria; Torres, Javiera; Caceres, Javier; Lizana, Rodrigo; Ramos, Liliana; et al. Article ISI SCOPUS CANCERS (2019)
Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer Hakkaart C.; Guilford P. Article ISI SCOPUS INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer Alvarez ManceÃ±ido F.; MartÃn Richard M.; Iglesias Rey L.; MartÃnez Lago N.; MartÃn Carnicero A.; HernÃ¡ndez PÃ©rez C. Article ISI SCOPUS THROMBOSIS AND HAEMOSTASIS (2019)
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry ViÃºdez A.; MacÃas I.; MartÃnez de Castro E.; Iglesia L.; Reguera P.; SÃ¡nchez-CÃ¡novas M.; LimÃ³n M.L.; MartÃnez-TorrÃ³n A.; Asensio E.; MartÃn-Carnicero A.; et al. Article ISI SCOPUS Clinical and Translational Oncology (2019)
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Borg C.; Doi T.; Savage M.J.; Shah S.; Wainberg, Z. A. Article ISI SCOPUS GASTRIC CANCER (2019)
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial Herbst, R. S.; Molina, J. R.; Dubos Arvis C.; Surmont V.; Shentu Y.; Samkari A. Article ISI SCOPUS ANNALS OF ONCOLOGY (2019)
Chilean Gastric Cancer Task Force A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients Owen, Gareth I.; Retamal, Ignacio N.; Fernadez, Maria F.; Cisternas, Betzabe; Acevedo, Francisco; Madrid, Jorge; Pena, Jose; Maturana, Maria Jose; Cordova-Delgado, Miguel; Torres, Javiera; et al. Article ISI MEDICINE (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial Doi T.; Jang, RW; Satoh, T; Machado M.; Sun, WJ; Jalal, SI; Shah, MA; Metges, JP; Golan, T; Mandala, M; et al. Article ISI SCOPUS JAMA ONCOLOGY (2018)
Angiogenesis inhibitors in early development for gastric cancer Pinto M, Owen GI; Retamal, Garrido M. Article EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer Sánchez Lorenzo M.L.; Plazas J.G.; Echavarría I.; Cano J.M.; Rodríguez Palomo A.; Mangas M.; Macías Declara I.; Visa L.; Viudez A.; Buxó E.; et al. Article ISI SCOPUS GASTRIC CANCER (2017)
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia García I.M.; Marcos, R; Castañon E.; Antonio, M; Font C.; Biosca M.; Blasco A.; Lozano R.; Ramchandani, A; Beato C.; et al. Article ISI SCOPUS BRITISH JOURNAL OF CANCER (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Herbst, R. S.; Baas, P; Felip, E; Molina J.; Arvis C.D.; Majem, M; de Castro, G; Garrido, M.; Shentu Y.; Im E.; et al. Article ISI SCOPUS LANCET (2016)
The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma Article Expert Review of Anticancer Therapy (2016)
Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer Jimenez-Fonseca, P; Solis, MP; Garrido, M.; Faez, L; Rodriguez D.; Ruiz, AL; Lorenzo, MLS; Uriol, E; Menendez, MD; Vieitez, JM Article ISI SCOPUS Clinical and Translational Oncology (2015)
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy Riquelme, I.; Saavedra, K; Weber, H; Garcia, P.; Nervi, B; Garrido, M.; Corvalyn, AH; Bizama, C Article ISI SCOPUS Oncotarget (2015)
Prediction of chemotherapy response and metabolism for the tailoring of ovarian cancer treatment Kato, Sumie; Garrido, Marcelo; Isabel Barriga, Maria; Barrena, Nicanor; Alonso, Catalina; Barra, Alejandro; Jimenez, Paula; Aguilar, Alfredo; Pinto, Joseph; Cuello, Mauricio; et al. Article ISI CANCER RESEARCH (2015)
Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study Carmona-Bayonas A.; Jimenez-Fonseca, P; Echaburu J.V.; Antonio, M; Font C.; Biosca M.; Ramchandani, A; Martinez J.; Cubero J.H.; Espinosa J.; et al. Article ISI SCOPUS JOURNAL OF CLINICAL ONCOLOGY (2015)
In vitro cell response to chemotherapeutic agents, to personalize ovarian cancer treatment. Report of two cases Ibañez, C; Garrido, M.; Medina, L; Kato S.; Bravo, ML; Gonzalez, P.; Oliva, B.; Pizarro J.; Bustamante, E; Brañes J.; et al. Article ISI REVISTA MEDICA DE CHILE (2013)
Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer Cells Erices, R.; Bravo, ML; Gonzalez, P.; Oliva, B.; Racordon D; Garrido, M.; Ibañez, C; Kato S.; Brañes J.; Pizarro J.; et al. Article ISI SCOPUS Reproductive Sciences (2013)
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases Galindo, J; Gabrielli, M; Guerra, JF; Cassina, JC; Garrido, M.; Jarufe, N.; Borghero, Y; Madrid J.; Zoroquiain, P; Martinez J. Article ISI SCOPUS World Journal of Surgical Oncology (2013)
Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays Quiroga T.; Goycoolea M.; Matus, V.; Zúñiga P; Martinez, C.; Garrido, M.; Aranda, E; Leighton F.; Panes O.; Pereira, J; et al. Article ISI SCOPUS BRITISH JOURNAL OF HAEMATOLOGY (2009)
Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile Rabagliati, R; Fuentes, G; Orellana E.; Oporto J.; Domínguez I.; Benitez, R; Aedo I.; Ramos G.; Garrido, M.; Garcia, P. Article ISI REVISTA CHILENA DE INFECTOLOGIA (2009)
Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile. Ricardo Rabagliati B., Gino Fuentes L.; Eric Orellana U., Jorge Oporto C.; Isabel Domínguez M., Rosana Benítez G.; Igor Aedo C., Germán Ramos G. Article Revista Chilena de Infectología. (2009)
Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Catolica, Santiago-Chile using revised EORTC/MSG diagnostic criteria Rabagliati, R; Fuentes, G; Orellana E.; Oporto J.; Aedo I.; Garrido, M.; Nervi, B Article ISI REVISTA CHILENA DE INFECTOLOGIA (2009)
Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer Garrido, M.; Ramirez, P; Risueno, C; Orellana E.; Galindo, H; Álvarez, M Article ISI REVISTA MEDICA DE CHILE (2008)
Postoperative radio-chemotherapy in locally advanced gastric cancer Garrido, M.; Bustos M; Orellana E.; Madrid J.; Galindo, H; Sánchez, C; Pimentel, F; Guzman, S; Ibanez, L; Butte, JM; et al. Article ISI REVISTA MEDICA DE CHILE (2008)
Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy during pregnancy - Review of cases reported Garrido, M.; Clavero J.; Huete, A; Sánchez, C; Solar A.; Álvarez, M; Orellana E. Article ISI SCOPUS LUNG CANCER (2008)
Radio-quimioterapia postoperatoria en cáncer gástrico localmente avanzado Garrido, Marcelo; Bustos, Marisa; Orellana, Eric; Madrid, Jorge; Galindo, Héctor; Sánchez, César; Pimentel, Fernando; Guzmán, Sergio; Ibanez, Luis; Butte, Jean Michel; et al. Article SCIELO REVISTA MEDICA DE CHILE (2008)
Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer - Case report Garrido, M.; O'Brien A.; Gonzalez, S; Clavero, JM; Orellana E. Article ISI SCOPUS CHEST (2007)
Nuevas alternativas en el tratamiento del cancer gástrico avanzado Garrido, Marcelo; Melgoza, Geraldine; Galindo, Héctor; Madrid, Jorge; Sánchez, César; Nervi, Bruno; Alvarez, Manuel; Orellana, Eric Article SCIELO REVISTA MEDICA DE CHILE (2007)
Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4 chemotherapy) Garrido, M.; Melgoza, G.; Galindo, H; Madrid J.; Sánchez, C; Nervi, B; Álvarez, M; Orellana E. Article ISI REVISTA MEDICA DE CHILE (2007)
Treatment of metastatic gastrointestinal stromal tumors with Imatinib. Report of four cases Garrido, M.; Moncada M.; Tapia, G; Mendez, G; Galindo, H; Huete, A; Ibanez, L; Gonzalez, S; Álvarez, M Article ISI REVISTA MEDICA DE CHILE (2007)


Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059. Catenacci, DVT; Ku, GY; Bleeker, JS; Bang, YJ; Chung, HC; Hazzard, A Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2019)
Galectin 9 associates with PDL1 expression and promotes gastric cancer cell invasion Hill C.; Cabrolier, C; Pinto, MP; Bravo, ML Abstract ISI CANCER RESEARCH (2019)
Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study. Bang, YJ; Chung, HC; Salguero, HRC; Braghiroli, MIFM Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2019)
Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC). Breder, VV; Knox, JJ Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2019)
Development and validation of a Clinical Index of Severe Febrile Neutropenia: A prospective multicenter study Blasco A.; Martinez J.; Font C.; Rebollo, MA; Biosca M.; Ramchandani, A; Hernando-Cubero, J; Espinosa J.; Beato C.; Navalon, FJG; et al. Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2015)
KEYNOTE-010: Phase 2/3 study of pembrolizumab (MK-3475) vs docetaxel for PD-L1-positive NSCLC after platinum-based therapy Herbst, RS; Kim, DW; Felip, E; Perez-Gracia, JL; Garon, EB; Han, JY; Molina J.; Kim, JH; Gervais, R; Ahn, MJ; et al. Abstract ISI ANNALS OF ONCOLOGY (2015)
Personalized cancer therapy for ovarian cancer patients Aguilar, A; Valdiviezo, PI; Ibañez, C; Bravo, ML; Gonzales, P; Kato S.; Garrido, M.; Brañes J.; Pizarro J.; Leon, H; et al. Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2014)
Second-line FOLFOX chemotherapy in patients with metastatic gallbladder cancer and cholangiocarcinoma Leal, JL; Jarufe, N.; Madrid J.; Ibañez, C; Herrera, ME; Garrido, M.; Nervi, B Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2014)
Systemic Therapy in Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) and Ki Index 5-10% Jimenez-Fonseca, P; Carmona, A.; Faez, L; Solis, P; Rodriguez D.; Ruiz, L; Sánchez, L; Li, W; Uriol, E; Menéndez M.; et al. Abstract ISI NEUROENDOCRINOLOGY (2014)
Evaluation of reprimo, a p53-dependent G2 arrest mediator candidate, for monitoring response to treatment in gastric carcinoma Garrido, M.; Medina, L; Slako, M; Funke, R.; Corvalan, AH Abstract ISI JOURNAL OF CLINICAL ONCOLOGY (2011)
Adjuvant chemoradiotherapy for gastric adenocarcinoma, toxicity, survival and prognostic factors Besa, P; Garrido, M.; Bustos M; Pimentel, F; Crovari, F; Álvarez, M; Sánchez, C; Galindo, H; Orellana E.; Ibanez, L Abstract ISI INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)


Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649 Garrido, Marcelo; Gallardo, Carlos; Bragagnoli, Arinilda Silva Campos et al. ConferencePoster JOURNAL OF CLINICAL ONCOLOGY (2023)
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses Wang, Xuya; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan et al. ConferencePoster CANCER RESEARCH


A molecular subtype associated with p53 alterations identifies gastric cancer patients with poor response to chemotherapy plus immunotherapy treatments Garrido, Marcelo Proyecto (2022)
Mechanisms of resistance to immunotherapy based on checkpoint inhibitors in metastatic gastric cancers Garrido, Marcelo Proyecto (2018)
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer (CheckMate649) Bristol-Myers Squibb Proyecto (2016)
ROLE OF REPRIMO, A P53-DEPENDENT G2 ARREST MEDIATOR CANDIDATE, IN THE PATHOGENESIS OF HUMAN GASTRIC CARCINOMA. FONDECYT (1111014) Proyecto 2011-2013 Coinvestigador(a)


Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer Garrido, M.; Fonseca, PJ; Vieitez, JM; Frunza, M; Lacave, AJ Review ISI SCOPUS EXPERT REVIEW OF ANTICANCER THERAPY (2014)

Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Jaime Pereira

Jefe

Hematología-Oncología

ESCUELA DE MEDICINA, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Olga Panes

Technical Director/ Associated Research

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Diego Mezzano

Director

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Valeria Matus

Associate Researcher

Hematology-Oncology

P. UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Eduardo Aranda

Biochemist

Hematology

P. UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

jose valbuena

Associate Professor

Anatomic Pathology

PONTIFICIA UNIVERSIDAD CATOLICA. FACULTAD DE MEDICINA/ESCUELA DE MEDICINA/ DEPARTAMENTO DE ANATOMÍA PATOLÓGICA

santiago, Chile

Luis Quinones

PROFESOR TITULAR

ONCOLOGIA BASICO-CLINICA

UNIVERSIDAD DE CHILE

Santiago, Chile

Ricardo Armisen

Associate Professor

Centro de Genética y Genómica

Universidad del Desarrollo

Santiago, Chile

Patricia García

Jefe de Laboratorio de Microbiologia

Escuela de Medicina

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE, LABORATORIO DE MICROBIOLOGÍA

Santiago, Chile

Marcelo Garrido

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Mauricio Cuello

Profesor Titular

Ginecologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE. CENTRO DE INVESTIGACIONES MÉDICAS (CIM)

Santiago, Chile

Luis Cortínez

Profesor Titular

DIVISIÓN DE ANESTESIOLOGÍA

Pontificia Universidad Católica de Chile

Santiago, Chile

José Zoroquiain

PONTIFICIA UNIVERSIDAD CATÓLICA

SANTIAGO, Chile

Arnoldo Riquelme

Profesor titular

Gastroenterología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, DEPARTAMENTO DE GASTROENTEROLOGÍA

Santiago, Chile

Cesar Sanchez

Profesor asistente

Hematologia-oncologia

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

santiago, Chile

Franz Villarroel

Jefe Laboratorio - PI

Departamento de Investigación del Cáncer

Fundación Arturo López Pérez

Santiago, Chile

Nicolas Jarufe

Chief Digestive Surgery

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Juan Roa

Chair

Pathology

Pontificia Universidad Catolica de Chile

santiago, Chile

ALEJANDRO CORVALAN

Principal Investigator

Hematology and Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

Bruno Nervi

Associated Professor

Hematology - Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

Alberto Martin

Associate professor

Centro Ciencia & Vida

Universidad San Sebastián

Santiago, Chile

Patricia García

Profesor Asistente

ANATOMIA PATOLOGICA

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

Carolina Serrano

Profesor Asistente Ordinario

Pediatric Gastroenterology and Nutrition

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

MARIA DURAN

Estudiante

Universidad Mcgill

Montreal, Canada

Manuel Espinoza

Profesor Asociado

Salud Pública

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

Ismael Riquelme

Académico - Investigador

Ciencias de la Salud

UNIVERSIDAD AUTÓNOMA DE CHILE

Temuco, Chile

Mauricio Pinto

Investigador

STORM SPA

Santiago, Chile

Carolina Bizama

Assistant professor

Department of Pathology

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

María Rodríguez

Profesora Asociada

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

Rafaela Erices

Postdoctorante

Ginecología y Obstetricia

Pontificia Universidad Católica de Chile

Santiago, Chile

Ignacio Retamal

Assistant Professor

Centro de Oncología de Precisión

Universidad Mayor de Chile

Santiago, Chile

JUVENAL RÍOS

Investigador

CR de Investigación y Desarrollo

Instituto Nacional del Cáncer (INCANCER)

Santiago, Chile

Martin Inzunza

Fellow simulación

Cirugía

Pontificia Universidad Católica de Chile

Santiago, Chile

mauricio cuello

Eduardo Fuentes

Profesor Asistente

Ciencias de la Salud

Universidad Católica de Chile

Santiago, Chile

Helga Weber

Investigador

Vicerrectoría de Investigación y Post Grado

Universidad de la Frontera

Temuco, Chile

Tomas de Mayo

PROFESOR ASOCIADO

CIENCIAS

UNIVERSIDAD MAYOR

SANTIAGO, Chile

María Maturana

Bioquimico

Pontificia Universidad Católica de Chile

Santiago, Chile

Francisco Barrera

Profesor Asociado

Gastroenterología

Pontificia Universidad Católica de Chile

Santiago, Chile

Francisco Acevedo

Medico Oncologo

Hemato Oncologia

Pontificia Universidad Católica de Chile

Santiago, Chile

pamela zuñiga

Profesor Asociado

Pediatria

Pontificia Universidad Católica de Chile

Santiago , Chile

Charlotte Hill

Postdoctoral Fellow

CIIB

Universidad de Los Andes

Santiago, Chile

Miguel Cordova

Estudiando de Doctorado

Departamento de Posgrado

Universidad de Chile

Santiago, Chile

Mauricio Hernandez

Chief Laboratory Officer

Proteogenomica

MELISA Institute

San Pedro de la Paz, Chile

Erica Koch

Oncólogo Médico

Red de Salud UC Christus

Santiago, Chile

Sergio Riveros

Residente

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

FERNANDO CROVARI

Jefe Departamento

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

Martin Dib

Jefe Programa de Trasplantes UC

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

Natalia Landeros

Profesor Asistente

Ciencias Preclínicas

Universidad Católica del Maule

Talca, Chile

Ignacio Wichmann

Assitant Professor

Obstetrics

Pontificia Universidad Católica de Chile

Santiago, Chile

Leonel Muñoz

Profesor Adjunto

Escuela de Medicina

Universidad de Valparaíso

Viña del Mar, Chile

Sebastian Morales

Académico e Investigador

Facultad de Medicina y Ciencias de la Salud

Universidad Mayor de Chile

Santiago, Chile

Ana Guzman

MÉDICO JEFE LABORATORIO

LABORATORIO CLÍNICO

PONTIFICIA UNIVERSIDAD CATÓLICA

SANTAIGO, Chile

José Clavero

Jefe Unidad

Cirugía

Clínica Universidad de Los Andes

Santiago, Chile

Matías Muñoz

Research Assistant

Universidad Mayor de Chile

Santiago, Chile

Patricio Yañez

Director Programa Sub-especialidad en Oncología Médica

Especialidades Médicas

Universidad de La Frontera

Temuco, Chile

Thomas Uslar

Académico

Endocrinología

Pontificia Universidad Católica de Chile

Santiago, Chile

Ivania Valdes

Estudiante de Doctorado

Vicerrectoria de investigación

Universidad Mayor de Chile

Santiago, Chile

Pamela Salman

Full Professor

Facultad de Medicina y Ciencias de la Salud

Universidad Mayor de Chile

Santiago, Chile

Marcelo Adan Garrido Salvo

Líneas de Investigación

Educación

Medico cirujano, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1997

Internal Medicine, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2001

Sub-Specialization in Oncology and Hematology, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2007

Medicine, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1995

Training in gastrointestinal Oncology and Neuroendocrine Tumors, Hospital Universitario Central de Asturias. España, 2013

Experiencia Académica

Instructor Full Time

Profesor Asistente Full Time

Full professor of Dirección Innovación y Transferencia Tecnológica Full Time

Associated Professor Full Time

Experiencia Profesional

Medico intensivista Full Time

Medical director Part Time

Chief of Onco-Hematology, Medical Oncology and Gastrointestinal Oncology Part Time

Principal Investigator Part Time

Gastrointestinal Oncology and Oncology Clinical Trials Part Time

Premios y Distinciones

Beca Presidente de la Republica

Premio al mejor graduado

Beca Medicina Interna

Beca de Oncologia

Prominent Oncologist Prize

Article (84)

Abstract (11)

ConferencePoster (2)

Proyecto (4)

ROLE OF REPRIMO, A P53-DEPENDENT G2 ARREST MEDIATOR CANDIDATE, IN THE PATHOGENESIS OF HUMAN GASTRIC CARCINOMA.

Review (1)